Certain genotypes of several genetic polymorphisms in enzymes involved in the metabolism of xenobiotics (such as CYP1A1) or in DNA repair genes have been suggested to alter the risk of breast cancer [25,26]. Here, CYP1A1 is linked to breast carcinoma.